(19)
(11) EP 3 601 565 A1

(12)

(43) Date of publication:
05.02.2020 Bulletin 2020/06

(21) Application number: 18777343.7

(22) Date of filing: 23.03.2018
(51) International Patent Classification (IPC): 
C12N 15/11(2006.01)
C12N 15/113(2010.01)
(86) International application number:
PCT/US2018/024167
(87) International publication number:
WO 2018/183127 (04.10.2018 Gazette 2018/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.03.2017 US 201762476780 P
27.03.2017 US 201762477385 P

(71) Applicant: Miragen Therapeutics, Inc.
Boulder, CO 80301 (US)

(72) Inventors:
  • HINKEL, Rabea
    Boulder, Colorado 80301 (US)
  • KUPATT, Christian
    Boulder, Colorado 80301 (US)
  • DIMMELER, Stefanie
    Boulder, Colorado 80301 (US)

(74) Representative: Cooley (UK) LLP 
Dashwood 69 Old Broad Street
London EC2M 1QS
London EC2M 1QS (GB)

   


(54) MIR-92 INHIBITORS FOR TREATMENT OF HEART FAILURE